stockrow
Friday 6 November 2026
Export BIOA’s income statement to Excel — free account
BioAge Labs, Inc.
BIOA Healthcare Drug Manufacturers Specialty & Generic
BioAge Labs, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.0 million.
- Revenue
- −85.5%
- EPS
- −30.4%
- Free cash flow
- −92.8%
- Total debt
- −83.6%
Quarter to September 2026, against a year earlier
5.30
0.24
−4.33%
Follow BIOA
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(27.09%) | (25.98%) | (28.21%) | (34.56%) | |
| (24.68%) | (24.26%) | (26.27%) | (32.05%) | ||
ROIC |
0.00% | 0.00% | (118.25%) | (21.75%) | |
Return on Tangible Assets |
(30.12%) | (23.84%) | (30.25%) | (38.89%) | |
Average Days of Receivables |
31.20 | 25.09 | 22.03 | 23.98 | |
Free Cash Flow per Share |
(6.60) | (5.73) | (5.42) | (5.61) | |
Free Cash Flow |
(237.09) | (243.38) | (242.84) | (257.75) | |
Capital Expenditures |
(155.47) | (155.07) | (155.23) | (155.23) | |
| Other line items | |||||
Cash ROIC |
(42.66%) | (31.88%) | (35.01%) | (74.40%) | |
Accounts Receivable Turnover |
0.00 | 19.28 | 16.86 | 15.92 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
822.30% | 807.16% | 847.78% | 1,157.20% | |
Selling, General and Administrative Expense of Revenue |
309.16% | 278.77% | 278.49% | 344.61% | |
Share Based Compensation of Revenue |
129.97% | 126.00% | 135.57% | 184.80% | |
Interest Coverage |
(133.11) | (211.45) | (378.19) | — | |
Operating CF/Net income |
1.01 | 0.98 | 0.93 | 0.95 | |
Depreciation/Fixed assets |
0.22 | 0.21 | 0.21 | 0.25 | |
Capex/Depreciation |
(729.89) | (648.81) | (618.47) | (550.46) | |
Revenue per Share |
0.25 | 0.24 | 0.23 | 0.19 | |
Operating CF per Share |
(2.27) | (2.08) | (1.95) | (2.23) | |
Capex per Share |
(4.33) | (3.65) | (3.46) | (3.38) | |
Capex to Sales |
17.28 | 15.03 | 14.99 | 18.05 |
Columns are period end dates · fundamentals updated 5 Nov 2026